Week 529 Review - Good week despite some big drops.

Not a bad week, with some decent rises making up for some depressing drops. The deficit between cost and value narrowed by £4,005 to £142,246 and the deficit between injection and value reduced to £63,416. Total portfolio value increased to £112,816.

Worst performer was last week's Share of the Week CWR:Ceres Power, which dropped 11% after lackluster interims and likely profit taking following the 44% rise last week.

TRX:Tissue Regenix had a 2nd big drop in a row, falling 9% to go 85% down.

PBX:Probiotix Health dropped 7% and will likely continue to drift until there is some news.

AMP:Ampeak Energy fell 5% after their interim results to go 74% down.

TLOU:Tlou Energy continue to yo-yo and dropped 5% this week to go 36% down.

CAPD:Capital rose 5% and it was a lot more than that in mid-week, allowing me to sell my SIPP holding. My remaining dealing account holding is 10% down and hopefully I can sell it soon.

RIO:Rio Tinto went up 5% but still seems to be lagging the other miners. My holding is only 4% down and I'm tempted to buy more when my pension transfer comes in a couple of weeks.

FDM:FDM Group recovered 6% of their recent losses but are still 60% down.

BOKU:Boku climbed an impressive 7% and are now 13% in profit.

GGP:Greatland Resources went up 10% and are 25% in profit.

IES:Invinity Energy went up 10% after revealing quite a few projects to deliver their batteries may be eligible for grant aid.

CORE:Solidcore Resources finally seems to be catching up with the other gold miners, and climbed 15%, but my holding is still 76% down.

Share of the Week is OPTI:Optibiotix which went up 17%, helped by the CEO buying a load of shares and possibly in anticipation of Sweetbiotix news in the next few weeks.

Here's the ISA and shares portfolio after week 9 of year 11.

			Weekly Change
Cash	£73.08		+£0
Portfolio cost	£115,878.07		+£0
Portfolio sell value (bid price-commission)	£37,945.50	(-67.3%)	+£1,691.14
Potential profits	£128.60		+£74.25
Yr 11 Dividends	£0		+£0
Yr 11 Interest	£0.02		+£0
Yr 11 Profit from sales	£0		+£0
Yr 11 proj avg monthly profit	-£7.69	(-0.1%)	+£0.96
Total Dividends	£12,488.07		+£0
Total Interest	£8.59		+£0
Total Profit from sales	£17,560.27		+£0
Average monthly cash profit	£241.44	(3.3%)	-£0.46
(Sold stocks profit + Dividends - Fees / Months)

Potential profits went up £74 thanks to BOKU:Boku and total value went up a healthy £1,691. Year 11 performance should go positive in 2 weeks when a CAPD:Capital dividend comes through, but meantime is negative due to ISA fees.

Will it last more than a week?

Still below the trend line.

The SIPP looks like this after week 513 overall and week 45 of year 10.

			Weekly Change
Cash	£1,642.70		-£27.64
Portfolio cost	£137,470.05		+£239.26
Portfolio sell value (bid price - commission)	£73,155.64	(-46.8%)	+£2,314.24
Potential profits	£6,800.20		+£281.04
Yr 10 Dividends	£1,658.24		+£91.24
Yr 10 Interest	£4.00		+£0
Yr 10 Profit from sales	£6,948.31		+£57.88
Yr 10 proj avg monthly profit	£809.90	(10.9%)	-£3.72
Total Dividends	£17,774.89		+£91.24
Total Interest	£16.90		+£0
Total Profit from sales	£23,956.25		+£57.88
Average monthly cash profit	£339.29	(4.5%)	+£0.60

I sold my CAPD:Capital shares as they have fallen out of my top 50 in the magic formula and they had a brief spike in mid-week to allow me to take a profit. I sold 1,123 shares at 104.1p making £57.88 (5.2%) profit, or 7% if you include the £21 dividend, with another dividend still to come.

I bought 127 shares in KNOS:Kainos Group at 878.7p costing £1,133.48. They went up 1% after I bought them, but are 1% down due to commission. They are 9th on my magic formula ranking, but I had avoided them due to a long decline in share price. However they recently surged so seem to have some upward momentum. They pay a 3.87% dividend, have ROI of 20.79%, debt to equity of 4.03% and 5-year earnings per share growth of 13.31%. I now have 18 of my top 30 ranking shares, with 9 on my watch list and 3 written off for ethical or red flag reasons.

I also got a tax rebate in my AJ Bell account, so once again bought some more JLP:Jubilee Metals shares. I bought 6,584 at 3.0375p costing £204.99.

I had a £21 dividend from ARBB:Arbuthnot Banking, £43 from RIO:Rio Tinto, and £26 from SBRE:Sabre Insurance.

Year 10 performance remains above 10% with just 7 weeks of the year left to go, but long term profit remained flat at 4.5%, which is unchanged since the beginning of year 10, mainly because the cost of the portfolio has gone up quite a lot with regular injections.

I just can't close the gap to the injection line.

As with the ISA, still below the trend line

Trend line still upwards and we're above it.

Both JLP:Jubilee Metals and OPTI:Optibiotix are due an update in the next few weeks. JLP on copper production and progress on selling the South African operation, and OPTI on 2nd generation products. Seed Health have put out a teaser that they're launching something on 30th September. Could it possibly be the first product to contain Sweetbiotix? Probably not given the serial disappointment we're going through at the moment. It's nice to dream though.

Week 528 Review - Reasonable week spoiled by Optibiotix.

A reasonably good week ruined by OPTI:Optibiotix dropping 1.5p, undoing all the good from elsewhere and causing the deficit between cost and value to widen by £1,393 to a record £146,252, with the deficit between injection and value growing to £67,633. Total portfolio value dropping to £108,599.

Worst performer was last week's Share of the Week TLOU:Tlou Energy which fell 15% and undid last week's rise.

OPTI:Optibiotix dropped 10% which is about £3,000 so it's a good job other things went up.

TRX:Tissue Regenix dropped another 8% as they spiral away towards nothing.

FOUR:4imprint reversed the recent recovery and dropped 6% to go 29% down.

ARBB:Arbuthnot Banking dropped 5% to go 10% down just as I thought they were getting back into profit.

CORE:Solidcore Resources went up 6% but are still 79% down. I really need these to re-list in UK.

IPX:Impax Asset Management recovered last week's losses and went up 6% but are still 59% down.

GGP:Greatland Resources also recovered from last week's drop to go up by 7% and are now 14% in profit.

FXPO:Ferrexpo recovered 9% so are 89% down which means I have to report on them again.

AFC:AFC Energy recovered 10% and are now only 35% down.

ALU:Alumasc Group recovered 10% after recent drops and are now 71% up.

PAF:Pan African Resources continue to surprise, climbing another 10% to go 176% up as they prepare to list on the main market which should see them enter the FTSE index.

Share of the Week is CWR:Ceres Power which climbed a massive 44%, although my holding is still 34% down. Maybe things are starting to look up here.

Here's the ISA and shares portfolio after week 8 of year 11.

			Weekly Change
Cash	£73.08		-£8.00
Portfolio cost	£115,878.07		+£0
Portfolio sell value (bid price-commission)	£36,254.36	(-68.7%)	-£1,134.25
Potential profits	£54.35		+£0
Yr 11 Dividends	£0		+£0
Yr 11 Interest	£0.02		+£0.02
Yr 11 Profit from sales	£0		+£0
Yr 11 proj avg monthly profit	-£8.65	(-0.1%)	-£3.72
Total Dividends	£12,488.07		+£0
Total Interest	£8.59		+£0.02
Total Profit from sales	£17,560.27		+£0
Average monthly cash profit	£241.90	(3.3%)	-£0.53
(Sold stocks profit + Dividends - Fees / Months)

Cash dropped due to monthly fees and BOKU:Boku stayed flat so no change in potential profits.

And still the decline continues.

Dropping faster than the trend line now and almost off the bottom of the chart.

The SIPP looks like this after week 512 overall and week 44 of year 10.

			Weekly Change
Cash	£1,670.34		-£469.27
Portfolio cost	£137,230.79		+£484.47
Portfolio sell value (bid price - commission)	£70,602.14	(-48.6%)	-£259.25
Potential profits	£6,519.16		+£976.29
Yr 10 Dividends	£1,567.00		+£34.93
Yr 10 Interest	£4.00		+£0.04
Yr 10 Profit from sales	£6,890.43		+£0
Yr 10 proj avg monthly profit	£813.62	(10.9%)	-£17.39
Total Dividends	£17,683.65		+£34.93
Total Interest	£16.90		+£0.04
Total Profit from sales	£23,898.37		+£0
Average monthly cash profit	£338.69	(4.5%)	-£0.54

Although I was away on holiday, my monthly regular savings kicked in.

The first was BEZ:Beazley where I bought 31 shares at 797.26p costing £249.89. That reduced my weighted average to 926.73p. They went up to 837p just after I bought them, so my holding is only 11% down now.

The next purchase was a new investment. I bought 13 share in RAT:Rathbones at 1784p costing £234.58. These climbed to 1810p by the end of the week so I'm only 2% down due to commission. They are 23rd in my magic formula ranking, with dividend of 5.34%, ROI of 11.4%, debt to equity of 6.51% and 5 year earnings per share growth of 4.4%. Their share price had been rising steadily for 6 months before a blip at the end of August. I don't see them soaring, but hope they will be a reliable dividend payer.

I'm a bit miffed that one of my potential magic formula shares KNOS:Kainos Group which I was going to buy, I held back because their share price had been relentlessly declining. A few weeks ago it leapt from 700p to 900p so it goes to show it occasionally pays to catch a falling knife.

I got a £10 dividend from CKN:Clarkson and £24 from FOUR:4imprint, but also paid monthly fees. Value only dropped by £259 and potential profits zoomed up £976 thanks to my gold miners and ALU:Alumasc.

Still heading the wrong way.

Still below the trend line but at least no longer steeper than it.

I'm hoping this will stay fairly flat for a while now, as I don't really want to sell any more of my profitable shares. The next opportunity will probably be if CAPD:Capital continues to rise or if JLP:Jubilee Metals ever sorts itself out.

My biggest holdings are in a right mess at the moment, which is why I have a record deficit. OPTI:Optibiotix is at 9p and contributing £95,289 towards my deficit, which is 65% of it. My next biggest holding is JLP:Jubilee Metals which is contributing £20,893 to the deficit, which is 14% of it. Then we have PBX:Probiotix Health contributing £13,541 which is 9%. That means 88% of my losses are down to just 3 companies. If they could get to break-even my losses would only be £17,500 which would cause me to sleep easy. I would also be £61K above my injection line. The good news is that I'm reasonably confident all three will eventually come good, but I don't know how long it's going to take, and I'm fed up of writing doom and gloom week in and week out as my portfolio slides relentlessly downwards. I can just take heart that my new SIPP investments are doing much better and I have a process for buying shares which I hope will mean any new money is less likely to lose as much value as my previous purchases. 

Week 527 Review - Another losing week despite gold stocks rising well.

Another losing week, with the deficit between cost and value widening by £2,500 yo £144,858 and the deficit between injection and value widening to £66,246. Total portfolio value dropped to £109,986.

My biggest loser and a major contributor to the losses was CAML:Central Asia Metals which fell a massive 16% after lackluster results and a having of the dividend. A cynic might argue that they engineered the share price drop as they have instigated a share buy-back. It's very frustrating as I recently bought a load more and am now back to a big paper loss.

TRX:Tissue Regenix dropped 14% and I'm beginning to think I'll never get anything back from these as they are 82% down.

AMP:Ampeak Energy dropped 8% to go 72% down.

GGP:Greatland Resources suffered from some profit taking and dropped 5% but are still 7% up.

OPTI:Optibiotix continued to slide, and fell another 5% this week.

There was a lot more good news than last week, with INVP:Investec climbing 5% to go 2% into profit.

PRU:Prudential climbed 5% just one week after I bought them and are 5% in profit.

CORE:Solidcore Resources finally started reacting to the price of gold and went up 10%, but are still 80% down.

IES:Invinity Energy climbed 10% as they sold a few more batteries.

PAF:Pan African Resources continued to climb, rising another 10% to go 152% up.

SBTX:SkinBioTherapeutics had a rare rise of 10% but are still 28% down.

Share of the Week is TLOU:Tlou Energy, which does tend to bounce around a lot, but rose 13% this week.

Here's the ISA and shares portfolio after week 7 of year 11.

			Weekly Change
Cash	£81.08		+£0
Portfolio cost	£115,878.07		+£0
Portfolio sell value (bid price-commission)	£37,388.61	(-67.7%)	-£553.14
Potential profits	£54.35		-£14.85
Yr 11 Dividends	£0		+£0
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£0		+£0
Yr 11 proj avg monthly profit	-£4.93	(-0.1%)	+£0.82
Total Dividends	£12,488.07		+£0
Total Interest	£8.57		+£0
Total Profit from sales	£17,560.27		+£0
Average monthly cash profit	£242.43	(3.4%)	-£0.46
(Sold stocks profit + Dividends - Fees / Months)

Not much happened while I was on holiday. Potential profits dropped £14 as BOKU:Boku fell yet again. £553 drop in value is pretty flat.

Still looks dreadful

Still below the trend line.

The SIPP looks like this after week 511 overall and week 43 of year 10.

			Weekly Change
Cash	£2,139.61		+£0
Portfolio cost	£136,746.32		+£0
Portfolio sell value (bid price - commission)	£70,376.92	(-48.5%)	-£1,947.45
Potential profits	£5,542.87		+£92.65
Yr 10 Dividends	£1,532.07		+£0
Yr 10 Interest	£3.96		+£0
Yr 10 Profit from sales	£6,890.43		+£0
Yr 10 proj avg monthly profit	£831.01	(11.1%)	-£19.79
Total Dividends	£17,648.72		+£0
Total Interest	£16.86		+£0
Total Profit from sales	£23,898.37		+£0
Average monthly cash profit	£339.23	(4.5%)	-£0.66

Massive drop in value compared to the ISA because I hold so much CAML:Central Asia Metals in this account, and potential profit only went up £92 as the gains in miners were offset by losses elsewhere.

Bad.

Dreadful.

Nice.

Another holiday catch-up week so nothing more to say.

Week 526 Review - Gold miners shine but not enough to recover a dreadful week elsewhere.

A pretty dreadful week across most of the portfolio, with gold miners the only ray of sunshine. The deficit between cost and value widened by £4,679 to £142,358 and the deficit between injection and value widened to £63,746. Total portfolio value dropped to £112,486.

Worst performer was PBX:Probiotix Health, dropping 13% despite pretty good results.

CWR:Ceres Power fell 12% and are now 54% down.

ALU:Alumasc Group dropped 9% and I really don't know why, but are still 53% up.

ASHM:Ashmore Group have been recovering slightly recently but all that was undone as they dropped 9% to go 42% down.

OPTI:Optibiotix also dropped 9% which caused a significant proportion of this week's losses.

IPX:Impax Asset Management fell 6% and are now 62% down, all on the back of the St James's Place contract loss, which seems way too big a drop as it was only about 15% of their income.

JLP:Jubilee Metals didn't rally for very long and dropped 6% this week, which was another big contributor to the losses.

AFC:AFC Energy fell 5% to go 40 % down.

FXPO:Ferrexpo also fell 5% to go 89% down which is just shy of the 90% where I'll no longer have to report on it.

IHP:Integrafin dropped 5% and are no longer in profit, but down 3% on my purchase price.

My only significan risers were my two gold miners. PAF:Pan African Resources climbed 11% to go 120% up, and Share of the Week goes to GGP:Greatland Resources which climbed 17% to go 12% into profit.

Here's the ISA and shares portfolio after week 6 of year 11.

			Weekly Change
Cash	£81.08		+£0
Portfolio cost	£115,878.07		+£0
Portfolio sell value (bid price-commission)	£37,941.75	(-67.3%)	-£2,521.31
Potential profits	£69.20		-£19.80
Yr 11 Dividends	£0		+£0
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£0		+£0
Yr 11 proj avg monthly profit	-£5.75	(-0.1%)	+£1.16
Total Dividends	£12,488.07		+£0
Total Interest	£8.57		+£0
Total Profit from sales	£17,560.27		+£0
Average monthly cash profit	£242.89	(3.4%)	-£0.46
(Sold stocks profit + Dividends - Fees / Months)

BOKU:Boku dropped again so potential profits slipped by £19, and a thumping great drop in value.

All the recent gains have gone.

Nearly got to the trend line, but back below it now.

The SIPP looks like this after week 510 overall and week 42 of year 10.

			Weekly Change
Cash	£2,139.61		+£411.74
Portfolio cost	£136,746.32		+£564.73
Portfolio sell value (bid price - commission)	£72,324.37	(-47.1%)	-£2,158.67
Potential profits	£5,450.22		-£40.01
Yr 10 Dividends	£1,532.07		+£0
Yr 10 Interest	£3.96		+£0
Yr 10 Profit from sales	£6,890.43		+£726.47
Yr 10 proj avg monthly profit	£850.80	(11.4%)	+£56.03
Total Dividends	£17,648.72		+£0
Total Interest	£16.86		+£0
Total Profit from sales	£23,898.37		+£726.47
Average monthly cash profit	£339.89	(4.6%)	+£5.52

I decided my holding in III:3i Group had run its course. The premium to NAV is way over what it should be and they are utterly reliant on one investment, and I'd already sold half my original holding so dividend income was only going to be against 32 shares. I sold them for 3883.4p making £726.47 (140.7%) profit.

I used some of the proceeds to buy 110 shares in PRU:Prudential for 968.744p costing £1,075.95. I know they are not on my magic formula listing, but I've always wanted to invest and they are increasing in value at the moment, and are planning on selling off part of the company so there may be some shareholder returns.

Despite cashing in £726 profit, potential profit only dropped £40 thanks to the gold miners climbing so much. With just 10 weeks of year 10 left to go, my profit is 11.4% which is brilliant, but long term profit hardly budged and is half my target 10%. Cash went up £411 partly from the III sale and also from my £250 monthly savings.

Not looking as bad as the ISA

That is looking as bad as the ISA.

I'm liking this chart though!

Nothing more to say this week as I've been on holiday so catching up 3 weeks at once.

Week 525 Review - Lots of profits taken and Jubilee Metals rescues a bad week

A pretty poor week for most of the portfolio, with some big drops for magic formula shares and the SIPP absolutely hammered. However, thanks to a revival in JLP:Jubilee Metals, the deficit between cost and value only worsened by £246, and that's despite me realising £1,900 in profits, so it really feels like I'm £1,650 up. The deficit between cost and value is now £137,678 and the deficit between injection and value is down to £59,792. Total portfolio value increased to £116,190.

Worst performer was AMP:Ampeak Energy which re-branded from SAE:Simec Atlantis Energy and promptly dropped 11% to go 70% down.

FDM:FDM Group has been an utter disaster of a magic formula investment. It dropped 7% this week after a rally last week and is now 61% down. At some point I will probably buy more to average down, but not until the share price starts going up for some length of time.

IPX:Impax Asset Management looked like it might be creeping back up, but dropped 7% this week to go 59% down and join FDM as a disastrous investment. As with FDM, I will buy more but not until there is upward momentum, as their fundamentals remain strong.

PAGE:Pagegroup is in the same bracket as the two shares above, and also dropped 7% this week to go 53% down. They are still profitable and will turn around once people start recruiting staff again, at which point I will buy more.

PSN:Persimmon dropped 5% in a week most housebuilders got battered. These are now 27% down after being in profit not that long ago.

There was good news for ARBB:Arbuthnot Banking which went up 6% and is now only 2% down. Things are looking promising for these getting into profit, and they have returned to my top 50 ranking after briefly dropping out, so I will keep them.

Share of the Week was JLP:Jubilee Metals which went up 14% after the vote to sell the South African operation was passed. Hopefully that can generate revenue quickly and start a recovery in the share price, especially if we spend some of the cash on more copper assets in Zambia.

Here's the ISA and shares portfolio after week 5 of year 11.

			Weekly Change
Cash	£81.08		+£0
Portfolio cost	£115,878.07		+£0
Portfolio sell value (bid price-commission)	£40,463.06	(-65.1%)	+£1,536.07
Potential profits	£89.00		-£14.85
Yr 11 Dividends	£0		+£0
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£0		+£0
Yr 11 proj avg monthly profit	-£6.91	(-0.1%)	+£1.72
Total Dividends	£12,488.07		+£0
Total Interest	£8.57		+£0
Total Profit from sales	£17,560.27		+£0
Average monthly cash profit	£243.35	(3.4%)	-£0.46
(Sold stocks profit + Dividends - Fees / Months)

I big rise of £1,536 mainly thanks to JLP:Jubilee Metals as I have 410k shares in this account. My holdings are still over 50% down, but I'm reasonably optimistic they will creep up over the next 18 months or so. I'll be holding the ones in this account for the long term, in the hope of massive dividends.

Potential profits dropped £14 as BOKU:Boku fell 1%, and Year 11 performance will remain negative until I can sell something or get a dividend, as the monthly fees are pulling it down.

Sneaking up.

Back on the trend line, but no sign of holding above it.

One day I'll sell something.

The SIPP looks like this after week 509 overall and week 41 of year 10.

			Weekly Change
Cash	£1,727.87		+£1,515.25
Portfolio cost	£136,181.59		+£413.15
Portfolio sell value (bid price - commission)	£73,918.31	(-45.7%)	-£1,782.79
Potential profits	£5,490.23		-£1,809.53
Yr 10 Dividends	£1,532.07		+£25.85
Yr 10 Interest	£3.96		+£0
Yr 10 Profit from sales	£6,163.96		+£1,902.55
Yr 10 proj avg monthly profit	£794.77	(10.7%)	+£189.04
Total Dividends	£17,648.72		+£25.85
Total Interest	£16.86		+£0
Total Profit from sales	£23,171.90		+£1,902.55
Average monthly cash profit	£334.37	(4.5%)	+£15.79

This is going to be complicated!

First of all I had some dividend cash and in the hope of a JLP:Jubilee Metals revival following the vote on disposing of the South African operation, I bought 5,000 shares at 3p costing £155. They are now worth £165 so it may have actually worked.

I'd been concerned about a couple of shares falling outside the top 50 of my refreshed magic formula rankings, but decided it was down to them having 0% ROI. I realised however, that if I remove ROI from the rankings, they still fell outside the top 50, and the reason I wasn't selling them was because I like them. That's going against the whole point of the magic formula system, as there are better value companies above them in the rankings.

The first one I sold was IGG:IG Group which had fallen to 139 in the rankings. I sold them for 1153.04p and made £617.01 (40.3%) profit. I'd also had £279 dividends, so my return was actually 59%. That liberated £2,132.

I completely forgot about my plan from last week to keep the cash and set up regular investments, which is very vexing, so I initially bought another 21 shares in RIO:Rio Tinto at 4614.9113p costing £985.93. That takes my holding up to 61 shares at an average of 4925.119p costing £3,055.19. They are currently down by just 8% after averaging down and the price rising after I bought them. They are only down 3% if you include the dividends. I like their exposure to copper, which I think is going to rocket soon.

The next purchase was a new share INVP:Investec. They are ranked 31st in my magic formula ranking, which only just qualifies them for purchase, but they have a strong 6% dividend, high growth over the last 5 years of 32%, no debt and an upward momentum since April this year. I bought 206 shares at 547.5p costing £1,145.44. The price dropped 1% after I bought them, so they are 4% down mostly on spread and commission. They are ex-dividend so unfortunately I'll have a bit of a wait until the next one.

I'd been watching GGP:Greatland Resources ever since they bought the Telpher mine and started generating pretty big profits that should fund their other exploration projects. I decided having all my gold investment in PAF:Pan African Resources was a little risky, so it was time to top-slice a little profit and move some of it into GGP. I sold 1,912 shares at 62.6602p making £599.15 (100%) profit and liberated £1,186.11. I bought 455 shares in GGP at 266.6999p costing £1,225.43. Although the offer price stayed at 270p, the spread is quite wide so the bid price is 3% below that and my holding is 4% down if you add commission.

The next share to fall out of the top magic formula rankings was AJB:AJ Bell which is now 129th. I sold my 330 shares at 511.331p making £686.40 (68.5%) profit and liberating £1,682.39. This time I remembered my plan to hold the cash and buy small monthly investments of £250.

I added RAT:Rathbones Group to my next investment on 10th September, as they are 23rd in my Magic Formula ranking with a 5.34% dividend, 11.4% ROI, 6.51% debt to equity ratio and 4.4% 5-year earnings per share growth. They have been on a big rise since April but have dropped a little recently. I'm hoping the momentum is still upwards.

My other addition is PRU:Prudential, which is ranked 125th in my magic formula due to high debt and low dividend, but I've wanted to invest in it for ages and there's a possibility of some good shareholder returns as they sell off part of the business, so although I may regret turning my back briefly on the magic formula, I want to add them to my portfolio. These will also appear on 10th September and I have enough cash to keep this up for 3 months, and can hopefully generate £500 between now and 10th December to make it 4 purchases and around £1,000 in each investment.

Given I made £1,902 profit and potential profits only dropped by £1,809, the other profits increased by about £100.

The profits took my Year 10 performance past my target 10% to 10.7%, and if I sell nothing else in Year 10, I will still earn 8.4% which would be the best year for a while. I am however expecting lots more dividends, so as long as I don't realise a loss, it's looking good. My long term performance only improved by £15 a month and 0.2% to 4.5%, so it's going to take some epic profits to get up to 10%. I'm hoping JLP:Jubilee Metals will deliver me some of that.

I also had a £25 dividend from UKW:Greencoat UK Wind.

Getting closer to the injection line, as that includes the cash.

The big drop to the trend line is due to taking all the profits, but I think it was a worthwhile sacrifice.

Look at that little beauty! I'd like to think this is evidence of the magic formula system bearing fruit.

I had a bit of a scare, as the website I use for my magic formula ratios has removed financials from the available options. Fortunately I discovered that if I view the summary page and paste "-ratios" in the URL, I can still get to the pages. The worry is that they are going to stop supporting that data, which would mean me having to find a new source of data for my calculations. Fortunately I won't be updating it for a year, although I do want to complete my new AIM magic formula rankings, which I should maybe do sooner rather than later, as that's how I found BOKU:Boku, but I've not yet included all AIM shares so it's not a proper ranking unless they are all included

Week 524 Review - Best week for a while.

A pretty good week across the whole portfolio, with the deficit between cost and value narrowing by £1,574 to £137,431 and the deficit between injection and value to £61,474. Total portfolio value has increased to £114,508.

The only big faller was ALU:Alumasc Group which dropped 6% for no obvious reason. Results are due in a couple of weeks so it could just be people selling before then in case they disappoint.

YU.:Yu Group went up 5% after a shaky start over the few weeks since I bought them. My holding is only down by 1% now.

CWR:Ceres Power has been very volatile and went up 7% this week, but my holding is still 46% down.

Share of the Week is FDM:FDM Group which went up 12% after a recent crash on underwhelming results. It suggests the drop was over-done but my holding is still down 58%.

Here's the ISA and shares portfolio after week 4 of year 11.

			Weekly Change
Cash	£81.08		+£0
Portfolio cost	£115,878.07		+£0
Portfolio sell value (bid price-commission)	£38,926.99	(-66.4%)	+£544.09
Potential profits	£103.85		+£39.60
Yr 11 Dividends	£0		+£0
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£0		+£0
Yr 11 proj avg monthly profit	-£8.63	(-0.1%)	+£2.88
Total Dividends	£12,488.07		+£0
Total Interest	£8.57		+£0
Total Profit from sales	£17,560.27		+£0
Average monthly cash profit	£243.81	(3.4%)	-£0.47
(Sold stocks profit + Dividends - Fees / Months)

Fairly quiet. Portfolio value went up £544 and potential profits by £39 thanks to BOKU:Boku going up 4%. Most holdings were up a small amount and OPTI:Optibiotix was flat.

A few weeks of positive momentum

Going in the right direction, but still below the trend line.

The SIPP looks like this after week 508 overall and week 40 of year 10.

			Weekly Change
Cash	£212.62		+£62.50
Portfolio cost	£135,768.44		+£0
Portfolio sell value (bid price - commission)	£75,287.95	(-44.5%)	+£1,030.16
Potential profits	£7,299.76		+£262.56
Yr 10 Dividends	£1,515.52		+£0
Yr 10 Interest	£3.96		+£0
Yr 10 Profit from sales	£4,261.41		+£0
Yr 10 proj avg monthly profit	£605.73	(8.1%)	-£15.53
Total Dividends	£17,622.87		+£0
Total Interest	£16.86		+£0
Total Profit from sales	£21,269.35		+£0
Average monthly cash profit	£318.58	(4.3%)	-£0.63
(Sold stocks profit + Dividends - Fees / Months)

Cash went up thanks to a tax rebate, portfolio value up £1,030 and potential profits up £262 greatly helped by CAML:Central Asia Metals going into profit.

Maintaining the gap below the injection line

Above the trend line at last.

OPTI:Optibiotix released two lots of reasonably good news this week and still remained flat, so there remains little hope of any sort of share price recovery until some big Sweetbiotix news hits, and there's still no prospect of that. Meanwhile it's the EGM for JLP:Jubilee Metals on Thursday so we should get the vote for selling South African operations, and there's a vague possibility a yes vote will have a positive effect on the share price.

Week 523 Review - A dreadful week rescued by Optibiotix.

It was a bad week across most of the portfolio, but a good week for OPTI:Optibiotix rescued it and the deficit between cost and value reduced by £1,633 to £139,005 despite me taking £580 profits. The deficit between injection and value narrowed to £63,111 and total portfolio value increased to £112,871.

The biggest faller was BEZ:Beazley which dropped 14% after H1 results, which seemed way over-done considering they were still very profitable. My holding is now 20% down after just a few weeks, but I've re-set my monthly investment to these, as I'm anticipating them slowly moving back up, and I can average my price down over the next few months. My next purchase will be around 20th August so they will be cheap.

SAE:Simec Atlantis Energy dropped 13% which was likely profit taking after a big rise last week.

TLOU:Tlou Energy dropped 13% but it moves by that amount regularly.

SBTX:SkinBioTherapeutics dropped 11% after an underwhelming trading update saying revenue would be below expectations. They still look like becoming profitable by next year, and surely a Croda deal will be announced soon?

FXPO:Ferrexpo dropped 7% and are now 89% down, so if they drop next week I won't have to report it as they will pass the 90% down mark.

IES:Invinity Energy dropped 7% and I suspect will continue to slide until there's evidence of revenue coming in.

TRX:Tissue Regenix is another one that has a recent spike upwards and is now drifting back down, falling another 7% this week.

PSN:Persimmon gave solid H1 results but still slipped 5% and are now 25% down.

FOUR:4imprint crashed last week despite decent H1 results, but bounced back 6% this week. Fortunately my regular investment went through just before the rise, so my holding is only down by 24% which is significantly better than before I started buying a little each month. It is a really good way to buy shares. Unfortunately buying small amounts only really works with the monthly investment process, because the commission is just £1.50. I suppose if I built a decent cash buffer then I could put in multiple monthly purchases. It would mean I'd spend £6 on commission for every £1,000 instead of £5 but would give me the advantage of potentially buying cheaper shares or being able to switch strategy if I decide the company I picked was a mistake.

Share of the Week is OPTI:Optibiotix which went up 15% after announcing a new Slimbiome contract in USA. This is quite a big one and could see the company into profitability even without the Sweetbiotix revenue, if it ever appears. It's a while since we got a decent rise in OPTI though, and it nullified all the big drops everywhere else.

Here's the ISA and shares portfolio after week 3 of year 11.

			Weekly Change
Cash	£81.08		-£4.22
Portfolio cost	£115,878.07		+£0
Portfolio sell value (bid price-commission)	£38,382.90	(-66.9%)	+£1,016.53
Potential profits	£64.25		-£39.60
Yr 11 Dividends	£0		+£0
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£0		+£0
Yr 11 proj avg monthly profit	-£11.51	(-0.2%)	-£11.51
Total Dividends	£12,488.07		+£0
Total Interest	£8.57		+£0
Total Profit from sales	£17,560.27		+£0
Average monthly cash profit	£244.28	(3.4%)	-£0.50
(Sold stocks profit + Dividends - Fees / Months)

Not much happened. Monthly fees dropped cash by £4 and BOKU:Boku dropped 4% and knocked £39 off potential profits. OPTI:Optibiotix helped portfolio value go up by £1,016.

I've dropped the compound performance stat from the table above when I realised that it's just showing long term average monthly cash profit multiplied by the number of years I've been doing it, which is a waste of time.

Still grim

Still below the trend line

The SIPP looks like this after week 507 overall and week 39 of year 10.

			Weekly Change
Cash	£150.12		-£457.48
Portfolio cost	£135,768.44		+£1,043.72
Portfolio sell value (bid price - commission)	£74,257.79	(-45.3%)	+£616.84
Potential profits	£7,037.20		-£733.09
Yr 10 Dividends	£1,515.52		+£9.35
Yr 10 Interest	£3.96		+£0
Yr 10 Profit from sales	£4,261.41		+£580.29
Yr 10 proj avg monthly profit	£621.26	(8.4%)	+£50.51
Total Dividends	£17,622.87		+£9.35
Total Interest	£16.86		+£0
Total Profit from sales	£21,269.35		+£580.29
Average monthly cash profit	£319.21	(4.3%)	+£4.39
(Sold stocks profit + Dividends - Fees / Months)

Lots happened here.

First there was my regular monthly investment into FOUR:4imprint where I bought 7 shares at 3199.1185p costing £226.56. They ended the week at 3365p so it was a rare well-timed purchase.

I had some dividend money and the left overs from the monthly savings, so I also bought 92 shares in CAML:Central Asia Metals at 157.4727p costing £149.87. That's less than I would normally spend, but the £5 commission at AJ Bell makes smaller purchases a little more bearable than on HL where I pay £11.95.

I decided to sell BHP:BHP Group because the issue with the litigation from the burst dam years ago is still hanging around. It stopped my buying for years, and the fact it still hasn't gone away is too much of a worry, so I sold my 63 shares for 2004.452p and made £52.06 (4.3%) profit, or 5% if you include the £9 dividend. I went back to my magic formula and selected CKM:Clarkson, which is ranked number 11 and also ranks in the top 30 every time if I remove one of each of my four measures and re-rank. I bought 33 shares at 3574.104p costing £1,190.35. They dropped 3% since I bought them and are 4% down when you include spread and commission.

Next I decided to top-slice a little profit from PAF:Pan African Resources, as it was up by 102% and I could do so and still have over 10,000 shares. I sold 1,800 shares at 60.7476p making £528.22 (93.4%) profit. It was a shame I sold on a mini-dip, as it's now back at 102% up. I selected another magic formula share and bought 320 shares in FSV:Fidelity Special Values at 380.6p costing £1,235.96. They went up by 0% but are still 2% down on spread and commission.

The end result was the portfolio cost going up by £1,043, and value only going up £616 due to removing £580 profit. Potential profits dropped by £733 altogether so I lost another £253 on top of what I banked.

Year 10 performance is looking great at 8.4%, but long term performance only increased by 0.1% to 4.3% which is half of my original target 10%.

I also got a £9 dividend from GAW:Games Workshop.

Remarkable how I'm maintaining such an even gap beneath the injection line.

Just above the trend line but not enough to make any difference

This one's quite pleasing and suggests my magic formula approach may be bearing fruit. Unfortunately there's all the original stuff spoiling it, and they steadfastly refuse to increase enough for me to sell and switch to magic formula.

I am now at the stage where there are only 2 more magic formula shares I'm looking at. One is JHD:James Halstead and the other is KNOS:Kainos Group. The problem is they are both in steady share price decline, and I've learned my lesson from FDM:FDM Group that now is not a good time to buy them. The only way I can rescue myself with FDM is to start adding in my monthly investment once the price starts heading upwards. I did that successfully with IGG:IG Group and it seems to be happening with FOUR:4imprint too. I'm not catching a falling knife, but averaging down as their price heads up. With that in mind, all new purchases will be increasing my holdings in existing magic formula shares until I refresh the rankings next year.

Thinking more about what I mentioned in the FOUR:4imprint review at the top of the blog, I do quite like the idea of leaving a big lump of cash and setting up monthly investments with it. It means I earn interest on the cash, keep an emergency pot, and spread the risk when I'm buying shares. Next time I sell something I'm going to keep the cash and set up a new monthly investment for £250 and see how that works.